Skip to main content
logo
Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
3.280
+0.260 (8.61%)
At close: Oct 2, 2026, 4:00 PM EDT
3.220
-0.060 (-1.83%)
After-hours: Oct 2, 2026, 7:30 PM EDT

Basel Medical Group Financials Overview

Millions SGD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
14.7411.3510.059.7510.66
Revenue Growth
29.78%12.97%3.12%-8.55%-
Gross Profit
2.062.44.164.167.94
Operating Income
-4.34-2.142.222.46
Net Income
-10.05-10.642.071.781.98
Earnings Per Share
-6.01-6.791.531.321.46
EPS Growth
--16.23%-9.84%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
8.459.822.041.311.66
Total Debt
9.876.535.717.2110.15
Net Cash (Debt)
-1.423.29-3.67-5.9-8.49
Net Cash Growth
-----
Net Cash Per Share
-0.852.10-2.71-4.36-6.27

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-1.89-4.042.512.62.79
Capital Expenditures
-11-10.9-0.01-0.01-0.09
Free Cash Flow
-12.9-14.942.52.592.7
Free Cash Flow Growth
---3.56%-4.07%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
14.01%21.18%41.43%42.71%74.48%
Operating Margin
-29.43%-18.85%21.84%20.55%23.09%
Pretax Margin
-70.58%-97.35%23.92%21.87%22.39%
Profit Margin
-68.19%-93.67%20.62%18.30%18.56%
FCF Margin
-87.52%-131.58%24.89%26.61%25.37%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
0.413.75---